ImmunityBio (IBRX) Capital Expenditures Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.08% |
| Dec 31, 2025 | 26.91% |
| Jun 30, 2025 | -8.21% |
| Dec 31, 2024 | -51.89% |
| Sep 30, 2024 | 4.94% |
| Jun 30, 2024 | 24.58% |
| Mar 31, 2024 | -9.09% |
| Dec 31, 2023 | 26.54% |
| Sep 30, 2023 | 23.76% |
| Jun 30, 2023 | -37.00% |
| Mar 31, 2023 | 31.17% |
| Dec 31, 2022 | 15.05% |
| Sep 30, 2022 | -15.91% |
| Jun 30, 2022 | 8.73% |
| Mar 31, 2022 | -25.13% |
| Dec 31, 2021 | -59.96% |
| Sep 30, 2021 | 36.91% |
| Jun 30, 2021 | 31.04% |
| Mar 31, 2021 | 31.94% |
| Dec 31, 2020 | -22.26% |
| Jun 30, 2020 | 77.37% |
| Mar 31, 2020 | 57.39% |
| Dec 31, 2019 | 84.22% |
| Sep 30, 2019 | 64.71% |